Rebecca Meyer-Schuman Selected Research

Histidine-tRNA Ligase

1/2020	Bi-allelic mutations in HARS1 severely impair histidyl-tRNA synthetase expression and enzymatic activity causing a novel multisystem ataxic syndrome.
1/2018	Substrate interaction defects in histidyl-tRNA synthetase linked to dominant axonal peripheral neuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rebecca Meyer-Schuman Research Topics

Disease

1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2020
1	Usher Syndromes (Usher Syndrome) 01/2020
1	Type 2D Charcot-Marie-Tooth disease 12/2019
1	Microcephaly 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018

Drug/Important Bio-Agent (IBA)

2	Histidine-tRNA LigaseIBA 01/2020 - 01/2018
1	Amino Acids FDA Link 01/2020
1	EnzymesIBA 01/2020
1	Histidine (L-Histidine)FDA Link 01/2020
1	Transfer RNA (tRNA)IBA 01/2020
1	Glycine-tRNA LigaseIBA 12/2019
1	cysteinyl-tRNA synthetaseIBA 01/2019

Therapy/Procedure

1	Therapeutics 12/2019